People · Operator
Named in public records as an officer, director or promoter · active 2011–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aciex Therapeutics, Inc. | — | Biotechnology | Series A | $9.6M | $57.8M | 2011 |
Thomas Cavanagh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Cavanagh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jake Nunn | 1 | 5 |
| Dayton Misfeldt | 1 | 4 |
| Hal Werner | 1 | 1 |
| Raj Rai | 1 | 1 |
| Mark Abelson | 1 | 1 |
| Les Kaplan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.